skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

read more

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/21: Research Grant Cycle
Learn more

04/01/22: Fellow Exam Application Deadline
Learn more

06/01/22: Research Grant Cycle
Learn more

06/26/22: Membership Application Deadline to be eligible for AAOA Member rate for the 2022 Basic Course

08/01/22: Scientific Abstract Submission Deadline

09/01/22: Membership Application Deadline to be voted in at the 2022 Annual Meeting

EDUCATION

The education committee of the AAOA has put together an all-star lineup for this year’s virtual Annual Meeting taking place October 16th to 21st. Like last year, our Annual Meeting will offer live-stream and on-demand content. Some content will be available for self-paced on-demand viewing on September 15th, 2021. Learn More

IFAR

Available Now

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2021 AAOA Annual Meeting
Pre-launch Mid-September
Live Stream Starting on Oct 16 | Virtual
Learn More and Register

2022 AAOA Advanced Course
In-Person!!! Santa Fe, NM
January 13-15, 2022
Learn More and Register

2022 AAOA Basic Course
The Diptomat Beach Resort, Hollywood, FL
June 30-July 2, 2022

USP 797 Online Module
Learn More and Register

News and Updates

United Agrees To Give Physicians ERISA Rights in Connection with Repayment Demands

Bottom line Recent class action settlement gives all out-of-network (“ONET”) physicians important – and often overlooked –…

read more

Starting an Allergy Practice

The essential tools and pearls for a successful allergy practice by those who have done…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

How Does One Test for Allergies?

By Jodi Zuckerman MD, FAAOA

Allergy testing can be used to confirm that specific antigen triggers (grass, ragweed, dust mite, cat) produce a body response that triggers a histamine release and allergy cascade. Identifying these triggers can be helpful in treatment options of avoidance, medical management, and  immunotherapy. 

There are two main ways to test for allergies.  Both are measuring the response of the body to an allergen presentation.  The first possible way is through skin testing.  There are different methods of skin testing.  In skin prick testing, an antigen is presented to the skin with a small prick device at a very superficial level.  A response is measured by a resultant wheel that indicates how reactive or allergic you are to that allergen after waiting an allocated amount of time. 

The other form of skin testing is with a needle presenting the antigen to a deeper layer of skin.  This is called intradermal testing.  The response is also measured by the size of the wheel after presentation to the dermis of the skin.  Skin prick and intradermal testing can be used alone or in a combined fashion known as the modified quantitative testing where the response by skin prick will determine the concentration of antigen used to be applied to the dermis of the skin and this resultant reactivity is used as a safe endpoint of concentration of antigen for further immunotherapy. 

There are certain situations in which skin testing cannot be performed. Patients may be on medications that inhibit the response like tricyclic antidepressants, antihistamines, or medications that could interfere with emergency response of a severe reaction such as Beta-Blockers.  Skin disorders such as dermatographism and glycerine sensitivity may also require alternative testing. 

Allergy response can also be measured by a blood test looking specifically for antibodies that have been made in the blood that play a role in the allergic response when the specific allergen is encountered. This is commonly referred to as RAST (Radioallergoabsorbant Testing) and looks for the number of IgE antibiodies in the blood for a presumed antigen.  

Once the physician is able to review the results of the testing a guided treatment plan can be devised.  A positive test is not always significant and is taken in consideration with elements of the patient’s symptoms such as seasonality, exposures, and severity of symptoms.

Back To Top